Regis finds fresh growth levers as aged care funding pressure intensifies

Regis Healthcare delivered higher revenue, earnings and cash generation in FY26, but its new CEO is confronting a sharp funding gap across the aged care sector. The company plans to offset weaker AN-ACC support through pricing, cost reductions and further expansion.

  • Revenue rose 16% to A$1.35 billion and underlying EBITDA increased 10% to A$138 million
  • Operating cash flow reached A$336.3 million, leaving Regis with A$173.8 million of net cash
  • 2.55% AN-ACC indexation is below sector cost growth, according to management
  • Support office cuts and network savings are being rolled out through FY27, with full annualised benefits expected in FY28
  • More than 1,000 beds remain in the development pipeline, while Toowong opens this week
An image related to Regis Healthcare Limited A photo of the logo for Regis Healthcare Add us as a preferred source on Google
Image © middle. Logo © respective owner.

Strong FY26 cash generation meets a tougher funding environment

Regis Healthcare Limited (ASX:REG) enters its new financial year with a stronger balance sheet but a less forgiving funding equation. At its annual general meeting, the aged care operator reported FY26 revenue of A$1.35 billion, underlying EBITDA of A$138.0 million and statutory net profit after tax of A$55.7 million. Operating cash flow reached A$336.3 million, while net cash stood at A$173.8 million at 30 June 2026.

Photo from Regis Healthcare Limited’s announcement “AGM Presentations”
Image © Regis Healthcare Limited. From “AGM Presentations”, 17 Nov 2026.

The result gives the company room to keep investing, but management used the AGM to stress that the sector’s immediate problem is not demand. It is funding. CEO Andrew Kinkade said the Federal Government’s 2.55% AN-ACC indexation was below prevailing cost inflation and had been estimated by external experts to represent a funding shortfall of more than A$600 million across the sector. Regis said the announcement came as two-thirds of aged care homes were operating at a loss before the latest indexation decision.

Pricing and cost cuts are the first defence

Regis is responding by shifting more of its revenue mix towards residents and families, rather than relying solely on government funding. It said room prices for new residents had increased by about 10% in most homes in August, with the average fully paid residential accommodation deposit reaching A$750,000 in the first quarter of FY27, up 7% from a year earlier. The company has also launched a simplified Higher Everyday Living Fee offering.

The early-year figures are not uniformly favourable. Average occupancy was 95.6% in the first quarter, below the 96% average reported for FY26, and softer property market conditions reduced net RAD inflows as some residents and families instead chose to pay daily accommodation payments upfront. Regis said average accommodation pricing remained strong, but the change in payment preference matters because RAD inflows are an important source of capital for the business.

Management is also undertaking a substantial reduction in support office headcount and pursuing savings across procurement and the broader network. The full annualised benefit is expected in FY28, meaning the program will be judged over time rather than by an immediate earnings lift. The company has already pointed to more favourable contracts for trade waste, information technology and food as it tries to absorb wage, energy and food-cost pressure.

A freehold portfolio funds the next expansion phase

Regis’s growth case rests on the combination of operating earnings and resident-funded capital. Underlying EBITDA plus net RAD cash inflows reached A$388.5 million in FY26. The company now owns and operates 72 homes with about 8,250 operational beds, all held on a freehold basis, and says its development pipeline exceeds 1,000 beds.

That platform has been expanding through acquisitions and new construction. The Rockpool and OC Health transactions added about 830 beds during FY26, while the recently completed Royal Freemasons home care acquisition added approximately 500 clients in Melbourne and expanded Regis’s clinical nursing capability. The deal had earlier been positioned as a A$10 million annual revenue opportunity in Royal Freemasons acquisition, although the AGM presentation focused on the added clients and strategic reach rather than updating revenue guidance.

Regis will welcome its first residents at the 123-bed Toowong home this week, and has identified about 1,000 existing beds that could benefit from targeted refurbishment. Those projects are intended to improve amenity while supporting higher room prices and RADs. The company’s previous FY26 results coverage already highlighted the year’s 16% revenue growth and 10% EBITDA increase; the AGM added the harder question of how much of that momentum can be protected as funding growth slows.

New leadership inherits a growth strategy with execution risk

Photo from Regis Healthcare Limited’s announcement “AGM Presentations”
Image © Regis Healthcare Limited. From “AGM Presentations”, 17 Nov 2026.

Kinkade, who started as managing director and CEO in July, said he had visited all 72 homes and would focus on increasing resident-funded revenue, extracting more value from Regis’s scale and pursuing disciplined growth. The board also acknowledged Linda Mellors, who stepped down after almost seven years in the role and was credited with guiding the company through COVID-19, the Royal Commission and major workforce reform.

The strategic tension is straightforward: Regis has capital, demand and a sizeable property-backed pipeline, but new beds only make sense if funding and operating returns support the investment. Management argues that stronger consumer contributions, productivity improvements and selective consolidation can help close that gap without additional government expenditure. Whether those levers offset the AN-ACC shortfall will become clearer through FY27 occupancy, RAD trends, HELF uptake and the pace of delivered cost savings.

Get ASX:REG news the moment it breaks

Instant push notifications No waitlist Free
Download on the App Store iPhone & iPad
Get it on Google Play Android
Email alerts

Bottom Line?

Regis has the balance sheet to pursue growth, but FY27 will test whether pricing and efficiency gains can outrun the sector’s funding squeeze.

Questions in the middle?

  • Can higher room prices and HELF adoption compensate for slower government funding growth without weakening occupancy?
  • How quickly will the support office and network savings flow through earnings before the full FY28 benefit is realised?
  • Will the more than 1,000-bed pipeline continue to meet return hurdles under the revised AN-ACC funding settings?

Sources

1